arrow
A

Ann M. Kapoun

Tennessee Oncology
H指数:38
被引数:6,493

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GITRL-Fc biomarker and mechanism study: GITRL-Fc reduces Treg frequency in tumors and requires effector function for inhibition of tumor growth

Gitrl-fc生物标志物和机制研究: gitrl-fc降低肿瘤中Treg频率,并需要效应子功能来抑制肿瘤生长

2018-07-010
PRE
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC

抗癌干细胞DLL4-Binding剂Demcizumab联合培美曲塞和卡铂作为一线治疗转移性非鳞状NSCLC的IB期试验

2017-11-2965
PREAI